A mechanism of restricted human immunodeficiency virus type 1 expression in human glial cells

Journal of Virology

Volumn 70, Issue 11, 1996, Pages 7992-8002

  Shahabuddin, Muhammad ^a,c   Bentsman, Galina ^a   Volsky, Barbara ^a   Rodriguez, Isaac ^a,d   Volsky, David J ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d UNIVERSITY OF DELAWARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 160;

ARTICLE; GLIA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFE CYCLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; VIRUS CELL INTERACTION; VIRUS EXPRESSION; VIRUS REPLICATION;

EID: 0029842882     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.11.7992-8002.1996     Document Type: Article

References (102)

1. Adachi, A., H. E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M. A. Martin. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:284-291.
2. Alkhatib, G., C. Combadiere, C. C. Broder, Y. Feng, P. E. Kennedy, P. M. Murphy, and E. A. Bergert. 1996. CC CKR5: a RANTES. MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272: 1955-1958.
3. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl. 1987. Current protocols in molecular biology. Greene Publishing Associates and Wiley Interscience, New York.
4. Bagasra, O., S. P. Hauptman, H. W. Lischer, M. Sachs, and R. J. Pomerantz. 1992. Detection of human immunodeficiency virus type 1 provirus in mononuclear cells by in situ polymerase chain reaction. N. Engl. J. Med. 326:1385-1391.
5. Bhat, S., S. L. Spitalnik, F. Gonzalez-Scarano, and D. H. Silberberg. 1991. Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120. Proc. Natl. Acad. Sci. USA 88:7131-7134.
6. Boni, J., B. S. Emmerich, S. L. Leib, O. D. Wiestler, J. Scupbach, and P. Kleihues. 1992. PCR identification of HIV-1 DNA sequences in brain tissue of patients with AIDS encephalopathy. Neurology 43:1813-1817.
7. Brack-Werner, R., A. Kleinschmidt, A. Ludvigsen, W. Mellert, M. Neumann, R. Hermann, M. C. L. Khim. A. Burny, N. Muller-Lantzsch, D. Stavrou, and V. Erfle. 1992. Infection of human brain cells by HIV-1: restricted virus production in chronically infected human glial cell lines. AIDS 6:273-285.
8. Bruce, J., M. Rosenblum, K. Cronin, and R. W. Price. 1995. AIDS dementia complex and HIV-1 brain infection: clinical-virological correlations. Ann. Neurol. 38:563-570.
9. Budka, H. 1991. Neuropathology of human immunodeficiency virus infection. Brain Pathol. 1:163-175.
10. Casareale, D., M. Stevenson, K. Sakai, and D. J. Volsky. 1987. A human T-cell line resistant to cytopathic effects of the human immunodeficiency virus (HIV). Virology 156:40-49.
11. Cheng-Mayer, C., J. T. Rutka, M. L. Rosenblum, T. McHugh, D. P. Stites, and J. A. Levy, 1987. Human immunodeficiency virus can productively infect cultured human glial cells. Proc. Natl. Acad. Sci. USA 84:3526-3530.
12. Chesebro, B., R. Buller, J. Portis, and K. Wehrly. 1990. Failure of human immunodeficiency virus entry and infection in CD-4-positive human brain and skin cells. J. Virol. 64:215-221.
13. Chiodi, F., S. Fuerstenberg, M. Gidlund, B. Åsjö, and E. M. Fenyö. 1987. Infection of brain-derived cells with the human immunodeficiency virus. J. Virol. 61:1244-1247.
14. Choe, H., M. Farzan, Y. Sun, N. Sullivan, B. Rollins, P. D. Ponath, L. Wu, C. R. Mackay, G. LaRosa, W. Newman, N. Gerard, C. Gerard, and J. Sodroski. 1996. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85:1135-1148.
15. Clapham, P. R., D. Blanc, and R. A. Weiss. 1991. Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus type 1 and 2 and by simian immunodeficiency virus. Virology 181:703-715.
16. Clapham, P. R., J. N. Weber, D. Whitby, K. McIntosh, A. G. Dalgleish, P. J. Maddon, K. C. Deen, R. W. Sweet, and R. A. Weiss. 1989. Soluble CD4 blocks the infectivity of diverse strains of HIV SIV for T cells and monocytes but not for brain and muscle cells. Nature (London) 337:368-370.
17. Coburn, K. L., N. C. Moore, H. P. Katner, K. A. Tucker, W. S. Pritchard, and D. W. Duke. 1992. HIV and the brain: evidence of early involvement and progressive damage. Neuroreport 3:429-541.
18. Collman, R., J. W. Balliet, S. A. Gregory, H. Friedman, D. L. Kolson, N. Nathanson, and A. Srinivasan. 1992. An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1. J. Virol. 66:7517-7521.
19. Dawson, V. L., T. M. Dawson, G. R. Uhl, and S. H. Snyder. 1993. Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitricoxide in primary cortical cultures. Proc. Natl. Acad. Sci. USA 90:3256-3259.
20. Deng, H., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. Di Marzio, S. Marmon, R. E. Sutton, C. M. Hill, C. B. Davis, S. C. Peiper, T. J. Schall, D. R. Littman, and N. R. Landau. 1996 Identification of a major co-receptor for primary isolates of HIV-1. Nature (London) 381:661-666.
21. Dewhurst, S., K. Sakai, J. Bresser, M. Stevenson, M. J. Evinger-Hodges, and D. J. Volsky. 1987. Persistent productive infection of human glial cells by human immunodeficiency virus (HIV) and by infectious molecular clones of HIV. J Virol. 61:3774-3782.
22. Doranz, B. J., J. Rucker, V. Yi, R. J. Smyth, M. Samson, S. C. Peiper, M. Parmentier, R. G. Collman. and R. W. Doms. 1996. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85:1149-1158.
23. + cells is mediated by the chemokine receptors CC-CKR-5. Nature (London) 381:667-673.
24. Dreyer, E. B., P. K. Kaiser, J. T. Offermann, and S. A. Lipton. 1990. HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science 248:364-367.
25. Dubay, J. W., S. R. Dubay, H.-J. Shin, and E. Hunter. 1995 Analysis of the cleavage site of the human immunodeficiency virus type 1 glycoprotein: requirement of precursor cleavage for glycoprotein incorporation. J. Virol. 69:4675-4682.
26. Duensing, T. D., H. Fang, D. W. Dorward, and S. H. Pincus. 1995. Processing of the envelope glycoprotein gp160 in immunotoxin-resistant cell lines chronically infected with human immunodeficiency virus type 1. J. Virol. 69:7122-7131.
27. Dwek, R. A., C. J. Edge, D. J. Harvey, and M. R. Wormald. 1993. Analysis of glycoprotein-associated oligosaccharides. Annu. Rev. Biochem. 62:65-100.
28. Ensoli, F., A. Cafaro, V. Fiorelli, B. Vannelli, B. Ensoli, and C. J. Thiele. 1995. HIV-1 infection of primary human neuroblasts. Virology 210:221-225.
29. Epstein, L. G., L. R. Sharer, V. V. Joshi, M. M. Fojas, M. R. Koenigsberger, and J. M. Oleske. 1985. Progressive encephalopathy in children with acquired immune deficiency syndrome. Ann. Neurol. 17:488-496.
30. Feng, Y., C. C. Broder, P. E. Kennedy, and E. A. Berger. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272:872-877.
31. Franzusoff, A., A. M. Volpe, D. Josse, S. Pichuantes, and J. R. Wolf. 1995. Biochemical and genetic definition of the cellular protease required for HIV-1 gp160 processing. J. Biol. Chem. 270:3154-3159.
32. Gartner, S., P. Markovits, D. M. Markovits, M. H. Kaplan, R. C. Gallo, and M. Popovic. 1986. The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 233:215-219.
33. Gendelman, H. E., J. M. Orenstein, M. A. Martin, C. Ferrua, M. Mitra, T. Phipps, L. Wahl, H. C. Lane, A. S. Fauci, I. S. Burke, D. Skillman, and M. Meltzer. 1988. Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J. Exp. Med. 167:1428-1434.
34. Genis, P., M. Jett, E. W. Berton, T. Boyle, H. A. Gelbard, K. Dzenko, R. W. Keane, L. Resnick, Y. Mizrachi, O. J. Volsky, L. G. Epstein, and H. E. Gendelman. 1992. Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J. Exp. Med. 176:1703-1718.
35. Giulian, D., K, Vaca, and C. A. Noonan. 1990. Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science 250:1593-1596.
36. Golub, E. I., G. Li, and D. J. Volsky. 1990. Differences in the basal activity of the long terminal repeat determine different replicative capacities of two closely related human immunodeficiency virus type 1 isolates. J. Virol. 64:3654-3660.
37. Harouse, J. M., S. Bhat, S. L. Spitalnik, M. Laughlin, K. Stefano, D. H. Silberg, and F. Gonzalez-Scarano. 1991. Inhibition of entry of HIV-1 neural cell lines by antibodies against galactosyl ceramide. Science 253:320-322.
38. Harouse, J. M., C. Kunsch, H. T. Hartle, M. A. Laughlin, J. A. Hoxie, B. Wigdahl, and F. Gonzalez-Scarano. 1989. CD4-independent infection of human neural cells by human immunodeficiency virus type 1. J. Virol. 63:2527-2533.
39. Harouse, J. M., M. A. Laughlin, C. Pletcher, H. M. Friedman, and F. Gonzalez-Searano. 1991. Entry of human immunodeficiency virus-1 into glial cells proceeds via an alternate, efficient pathway. J. Leukocyte Biol. 49:605-609.
40. Harrington, R. D., and A. P. Geballe. 1993. Cofactor requirement for human immunodeficiency virus type 1 into a CD4-expressing human cell line. J. Virol. 67:5939-5947.
41. Hirt, B. 1967. Selective extraction of polyoma DNA from infected mouse cell culture. J. Mol. Biol. 26:365-369.
42. Jones, W. M., B. Walcheck, and M. A. Jutila. 1996. Generation of a new γδ T cell-specific monoclonal antibody (GD3.5). J. Immunol. 156:3772-3779.
43. + lymphocytes. J. Biol. Chem. 268:13406-13413.
44. Kim, S., R. Byrn, J. Groopman, and D. Baltimore. 1989. Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression. J. Virol. 63:3708-3713.
45. Kleinschmidt, A., M. Neumann, C. Moller, V. Erfle, and R. Brack-Werner. 1994. Restricted expression of HIV-1 in human astrocytes: molecular basis for viral persistence in the CNS. Res. Virol. 145:147-153.
46. Koenig, S., H. E. Gendelman, J. M. Orenstein, M. C. Dal Canto, G. H. Pezeshkpour, M. Yungbluth, F. Janolta, A. Aksamit, M. A. Martin, and A. S. Fauci. 1986. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233:1089-1093.
47. Kowalski, M., L. Bergeron, T. Dorfman, W. Haselline, and J. Sodroski. 1991. Attenuation of human immunodeficiency virus type 1 cytopathic effect by a mutation affecting the transmembrane envelope glycoprotein. J. Virol. 65:281-291.
48. Kunsch, C., and B. Wigdahl. 1991. Maintenance of human immunodeficiency virus type-1 proviral DNA in human fetal dorsal root ganglia neural cells following a nonproductive infection. J. Leukocyte Biol. 49:505-510.
49. Li, X. L., T. Moudgil, H. V. Vinters, and D. D. Ho. 1990. CD4-independent, productive infection of a neuronal cell line by human immunodeficiency virus type 1. J. Virol. 64:1383-1387.
50. Li, Y., J. C. Kappes, J. A. Conway, R. W. Price, G. M. Shaw, and B. H. Hahn. 1991. Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes. J. Virol. 65:3973-3985.
51. Lipton, S. A., and H. E. Gendelman. 1995. Dementia associated with the acquired immunodeficiency syndrome. N. Engl. J. Med. 332:934-940.
52. Lynch, W. P., W. J. Brown, G. J. Spangrude, and J. L. Portis. 1994. Microglial infection by a neurovirulent murine retrovirus results in defective processing of envelope protein and intracellular budding of virus particles. J. Virol. 68:3401-3409.
53. Maddon, P. J., A. G. Dalgleish, J. S. McDougal, P. R. Clapman, R. A. Weiss, and R. Axel. 1986. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47:333-348.
54. McCune, J. M., L. B. Rabin, M. B. Feinberg, M. Leiberman, J. C. Kosek, G. R. Reyes, and I. L. Weissman. 1988. Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus. Cell 53: 55-66.
55. Mizrachi, Y., I. Rodriguez, P. M. Sweetnam, A. Rubinstein, and D. J. Volsky. 1994. HIV type 1 infection of human cortical neuronal cells: enhancement by select neuronal growth factors. AIDS Res. Hum. Retroviruses 10:1593-1596.
56. Mizrachi, Y., M. Zeira, M. Shahabuddin, G. Li, F. Sinangil, and D. J. Volsky. 1991. Efficient binding, fusion and entry of HIV-1 into CD4 negative neural cells: a mechanism for neuropathogenesis in AIDS. Bull. Inst. Pasteur 89:81-96.
57. Moses, A. V., F. E. Bloom, C. D. Pauza, and J. A. Nelson. 1993. Human immunodeficiency virus infection of human brain capillary endothelial cells occurs via a CD4/galactosylceramide-independent mechanism. Proc. Natl. Acad. Sci. USA 90:10474-10478.
58. Moulard, M., T. Achstetter, Y. Ikehara, and E. Baharaoui. 1994. T4-lymphocyte endoprotease responsible for the proteolytic processing of HIV-1 gp160, like Kex2p endoprotease, is a calcium-dependent enzyme. Biochimie 76:251-256.
59. Myers, G., B. Korber, J. A. Berzofsky, T. F. Smith, and G. N. Pavlakis. 1995. Human retroviruses and AIDS. Los Alamos National Laboratory, Los Alamos. N.Mex.
60. Nath, A., V. Hartloper, M. Furer, and K. R. Fowke. 1995. Infection of human fetal astrocytes with HIV-1: viral tropism and the role of cell to cell contact in viral transmission. J. Neuropathol. Exp. Neurol. 54:320-330.
61. Navia, B. A., B. D. Jordan, and R. W. Price. 1986. The AIDS dementia complex. I. Clinical features. Ann. Neurol. 19:517-524.
62. Navia, B. A., and R. W. Price. 1987. The acquired immunodeficiency syndrome dementia complex as the presenting or sole manifestation of human immunodeficiency virus type infection. Arch. Neurol. 44:65-69.
63. Neumann, M., B. K. Felber, A. Kleinschmidt, B. Froese, V. Erfle, G. N. Pavlakis, and R. Brack-Werner. 1995. Restriction of human immunodeficiency virus type 1 production in a human astrocytoma cell line is associated with a cellular block in Rev function. J. Virol. 69:2159-2167.
64. Nuovo, G. J., F. Gallery, P. MacConnell. and A. Braun. 1994. In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids and tumor necrosis factor-α RNA in the central nervous system. Am. J. Patliol. 144:659-566.
65. Ohnishi, Y., T. Shioda, K. Nakayama, S. Iwata, B. Gotoh, M. Hamaguchi, and Y. Nagal. 1994. A furin-defective cell line is able to process correctly the gp160 of human immunodeficiency virus type 1. J. Virol. 68:4075-4079.
66. Pang, S., Y. Koyanagi, S. Miles, C. Wiley, H. V. Vinters, and I. S. Y. Chen. 1990. High levels of unintegrated HIV-1 DNA in brain lissue of AIDS dementia patients. Nature (London) 343:85-89.
67. Pellegrino, M. G., G. Li, M. J. Potash, and D. J. Volsky. 1991. Contribution of multiple rounds of viral entry and reverse transcription to expression of human immunodeficiency virus type 1. J. Biol. Chem. 266:1783-1788.
68. Poland, S. D., G. P. A. Rice, and G. A. Dekaban. 1995. HIV-1 infection of human brain-derived microvascular endothelial cells in vitro. J. Acquired Immune Defic. Syndr. Hum. Retroviruses 8:437-445.
69. Price, R. W., B. Brew, J. Sidtis, M. Rosenblum, A. C. Scheck, and P. Cleary. 1988. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 239:586-592.
70. Ranki, A., M. Nyberg, V. Ovod, M. Haltia, I. Elovaara, R. Raininko, H. Haapasalo, and K. Krohn. 1995. Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. AIDS 9:1001-1008.
71. Sabatier, J. M., E. Vives, K. Mabrouk, A. Benjouad, H. Rochal, A. Duval, B. Hue, and E. Bahraoui. 1991. Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1. J. Virol. 65:961-967.
72. Sadaie, M. R., V. S. Kalyanaraman, R. Mukopadhayaya, E. Tschachler, R. C. Gallo, and F. Wong-Staal. 1992. Biological characterization of non-infectious HIV-1 particles lacking the envelope protein. Virology 187:604-611.
73. Saito, Y., L. R. Sharer, L. G. Epstein, J. Michaels, M. Mintz, M. Louder, K. Golding, T. A. Cvetkovich, and B. M. Blumberg. 1994. Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues. Neurology 44:474-481.
74. Sakai, K., S. Dewhurst, X. Ma, and D. J. Volsky. 1988. Differences in cytopathogenicity and host cell range among infectious molecular clones of human immunodeficiency virus type 1 simultaneously isolated from an individual. J. Virol. 62:4078-4085.
75. Sanchez-Pescador, R., M. D. Power, P. J. Barr, K. S. Steimer, M. M. Stempien, S. L. Brown-Shimer, W. W. Gee, A. Renard, A. Randolph, J. A. Levy, D. Dina, and P. A. Luciw. 1985. Nucleotide sequence and expression of an AIDS-associated retrovirus. Science 227:484-492.
76. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467.
77. Shahabuddin, M., B. Volsky, H. Kim, K. Sakai, and D. J. Volsky. 1992. Regulated expression of human immunodeficiency virus type 1 in human glial cells: induction of dormant virus. Pathobiology 60:195-205.
78. Shapshak, P., N. C. J. Sun, L. Resnick, J. T. Thornthwaite, P. Schiller, M. Yoshioka, A. Svenningsson, W. W. Tourtellotte. and D. T. Imagawa. 1991 HIV-1 propagates in human neuroblastoma cells. J. Acquired Immune Defic. Syndr. 4:228-237.
79. Sharer, L. R. 1992. Pathology of HIV-1 infection of the central nervous system. J. Neuropathol. Exp. Neurol. 51:3-11.
80. Sharer, L. R., E. S. Cho, and L. G. Epstein. 1985. Multinucleated giant cells and HTLV-III in AIDS encephalopathy. Hum. Pathol. 16:760.
81. Shaw, G. M., M. E. Harper, and B. E. Hahn. 1985. HTLV-III infection in brains of children and adults with AIDS encephalopathy. Science 1:177-182.
82. Spencer, D. C., and R. W. Price. 1992. Human immunodeficiency virus and the central nervous system. Annu. Rev. Microbiol. 46:655-693.
83. Spire, B., J. Sire, V. Zachar, F. Rev, F. Barre-Sinoussi, F. Galibert, A. Hampe, and J. C. Chermann. 1989. Nucleotide sequence of HIV-1-NDK: a highly cytopathic strain of the human immunodeficiency virus. Gene 81: 275-284.
84. Srinivasan, A., R. Anand, D. York, P. Ranganathan, P. Feorino, G. Schochetman, J. Curran, V. S. Kalyanaraman, P. A. Luciw, and R. Sanchez-Pescador. 1987. Molecular characterization of human immunodeficiency virus from Zaire: nucleotide sequence analysis identifies conserved and variable domains in the envelope gene. Gene 52:71-82.
85. Srinivasan, A., D. Dorsett, D. York, C. Bohan, and R. Anand. 1988. Human immunodeficiency virus replication in human brain cells. Arch. Virol. 98: 135-141.
86. Stoler, M. H., T. A. Eskin, S. Benn, R. C. Angerer, and L. M. Angerer. 1986. Human T-cell lymphotropic virus type III infection of the central nervous system. JAMA 256:2360-2364.
87. Takahashi, K., S. L. Wesselingh, D. E. Griffin. J. C. McArthur, R. T. Johnson, and J. D. Glass. 1996. Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Ann. Neurol. 39:705-711.
88. Tornatore, C., R. Chandra, J. R. Berger, and E. O. Major. 1994. HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology 44:481-487.
89. Tornatore, C., K. Meyers, W. Atwood, K. Conant, and E. Major. 1994. Temporal patterns of human immunodeficiency virus type 1 transcripts in human fetal astrocytes. J. Virol. 68:93-102.
90. Tornatore, C., A. Nath, K. Amemiya, and E. O. Major. 1991. Persistent human immunodeficiency virus type 1 infection in human fetal glial cells reactivated by T-cell factor(s) or by the cytokines tumor necrosis factor alpha and interleukin-1 beta. J. Virol. 65:6094-6100.
91. Truckenmiller, M. A., H. Kulaga, M. Cogiano, R. Wyatt, S. H. Snyder, W. Wyatt, and P. M. Sweetnam. 1993. Human cortical neuronal cell line: a model for HIV-1 infection in an immature neuronal system. AIDS Res. Hum. Retroviruses 9:445-453.
92. Vesanen, M., T. Linna, and A. Vaheri. 1991. Persistent inapparent HIV-1 infection of human neuroblastoma cells. Arch. Virol. 120:253-261.
93. Volsky, B., K. Sakai, M. M. Reddy. and D. J. Volsky. 1992. A system for the high efficiency replication of HIV-1 in neural cells and its application to anti-viral evaluation. Virology 186:303-308.
94. Volsky, D. J., et al. Unpublished results.
95. Volsky, D. J., M. Shahabuddin, and Y. Mizrachi. 1992. The role of human immunodeficiency virus type 1 (HIV-1) in neurologic disorders of AIDS, p. 527-589. R. P. Roos (ed.), Molecular neurovirology. Humana Press, Totowa, N.J.
96. Watkins, B. A., H. H. Dorn, W. B. Kelly, R. C. Armstrong, B. J. Potts, F. Michaels, C. V. Kufta, and M. Dubois-Daleq. 1990. Specific tropism of HIV-1 for microglial cells in primary human brain cultures. Science 249: 549-553.
97. Weiser, B., N. Peress, D. La Neve, D. J. Eilbott, R. Seidman, and H. Burger. 1990. Human immunodeficiency virus type 1 expression in the central nervous system correlates directly with extent of disease. Proc. Natl. Acad. Sci. USA 87:3997-4001.
98. Westervelt, P., H. E. Gendelman, and L. Ratner. 1991 Identification of a determinant within the human immunodeficiency virus surface envelope glycoprotein critical for productive infection of primary monocytes. Proc. Natl. Acad. Sci. USA 88:3097-3101.
99. Wigdahl, B., R. A. Guyton, and P. S. Sarin. 1987. Human immunodeficiency virus infection of the developing human nervous system. Virology 159:440-445.
100. Wiley, C. A., R. D. Schrier, J. A. Nelson, P. W. Lampert, and M. B. A. Oldstone. 1986. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc. Natl. Acad. Sci. USA 83:7089-7093.
101. Willey, R. L., J. S. Bonifacino, B. J. Potts, M. A. Martin, and R. D. Klausner. 1988. Biosynthesis, cleavage, and degradation of the human immunodeficiency virus type 1 envelope glycoprotein gp160. Proc. Natl. Acad. Sci. USA 85:9580-9584.
102. Willey, R. L., T. Klimkait, D. M. Frucht, J. S. Bonifacino, and M. A. Martin. 1991. Mutations within the human immunodeficiency virus type 1 gp160 envelope glycoprotein alter its intracellular transport and processing. Virology 184:319-329.